Similar articles

• Selective inhibition of rat and human cardiac guanylate cyclase by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.

  Levey GS, Levey BA, Ruiz E, Lehotay DC. Levey GS, et al. Trans Assoc Am Physicians. 1979;92:303-8. Trans Assoc Am Physicians. 1979. PMID: 44927 No abstract available.
• Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity.

  Lehotay DC, Levey BA, Rogerson BJ, Levey GS. Lehotay DC, et al. Cancer Treat Rep. 1982 Feb;66(2):311-6. Cancer Treat Rep. 1982. PMID: 6120040
• Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.

  Levey BA, Ruiz E, Rogerson B, Lehotay DC, Levey GS. Levey BA, et al. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1127-8. Cancer Treat Rep. 1980. PMID: 6109566 No abstract available.
• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

  Gewirtz DA. Gewirtz DA. Biochem Pharmacol. 1999 Apr 1;57(7):727-41. doi: 10.1016/s0006-2952(98)00307-4. Biochem Pharmacol. 1999. PMID: 10075079 Review.
• Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.

  Aubel-Sadron G, Londos-Gagliardi D. Aubel-Sadron G, et al. Biochimie. 1984 May;66(5):333-52. doi: 10.1016/0300-9084(84)90018-x. Biochimie. 1984. PMID: 6380596 Review.